What Effect Did Medicare Part D Have on SSDI Medicare Beneficiaries?

Brett Alfrey

American Journal of Health Economics, 2024, vol. 10, issue 3, 437 - 469

Abstract: Medicare Part D expanded public prescription drug insurance coverage to millions of Social Security Disability Insurance (SSDI) Medicare beneficiaries. Using difference-in-differences estimation and data from the Medical Expenditure Panel Survey, I estimate the effect of Medicare Part D on the prescription drug coverage, utilization, and expenditures of this understudied group. I estimate that the policy increased prescription drug coverage by 18 percentage points and decreased annual out-of-pocket prescription drug expenditure by $526 (a decrease of 42 percent from the pre-reform mean). Additionally, the estimates suggest modest substitution away from private prescription drug coverage (decrease of 5.7 percentage points) and little decrease in annual private insurance prescription drug expenditure ($31). This would suggest large welfare gains from the policy for the Part D eligible SSDI population.

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://dx.doi.org/10.1086/724795 (application/pdf)
http://dx.doi.org/10.1086/724795 (text/html)
Access to the online full text or PDF requires a subscription.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ucp:amjhec:doi:10.1086/724795

Access Statistics for this article

More articles in American Journal of Health Economics from University of Chicago Press
Bibliographic data for series maintained by Journals Division (pubtech@press.uchicago.edu).